Syngene International Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot
SYNGENE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Smallcap 250 and in line with its Healthcare Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Syngene International has informed the exchanges that all five special resolutions in its Postal Ballot (Notice dated April 23, 2025) have been passed with the requisite majority. The resolutions approved the appointment of Mr. Peter Bains as Managing Director and CEO (with remuneration capped at 7% of net profits), the appointment of Dr. Sanjaya Singh and Mr. Suresh Narayanan as Independent Directors, amendments to increase the share pool under the Syngene Long Term Incentive Performance Share Plan 2023, and extending LTIP benefits to employees of the holding company and subsidiaries. Voting was conducted via e-voting, with about 90.25% of total equity capital participating. The director appointments and CEO appointment received overwhelming support (97% to nearly 100% in favour), while the LTIP amendments and extension received around 80.7% support, with institutional investors notably split (about 46% dissenting on the LTIP resolutions).
Shareholders have formally approved a new MD & CEO and two new Independent Directors, signalling leadership transition. The LTIP-related resolutions passed but with significant institutional dissent (~46%), which investors should monitor as it reflects some shareholder concern over expanded stock-based compensation.